Stability of Protein Pharmaceuticals
Part B: In Vivo Pathways of Degradation and Strategies for Protein Stabilization
Published on 30. November 1992
Book
Hardback
XXVI, 328 pages
978-0-306-44153-0 (ISBN)
Description
Part B explores protein degradation occuring
in vivo
during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability.
Reviews / Votes
` Offers the most comprehensive treatment to date of the various degradation pathways of pharmaceutical proteins....The two-volume set is an essential reference for pharmaceutical scientists. 'BioPharm
More details
Series
Edition
1992 ed.
Language
English
Place of publication
New York
United States
Publishing group
Springer Science+Business Media
Target group
Professional and scholarly
Research
Product notice
sewn/stitched
Cloth over boards
Illustrations
XXVI, 328 p.
Dimensions
Height: 236 mm
Width: 161 mm
Thickness: 24 mm
Weight
653 gr
ISBN-13
978-0-306-44153-0 (9780306441530)
Schweitzer Classification
Content
Improper Glycosylation and the Cellular Editing of Nascent Proteins; D.A. Cumming. Protein Aggregation In Vivo; R. Wetzel. Pathways of Intracellular Protein Degradation in Eukaryotic Cells; T.S. Olson, et al. Effects of Aging on Proteins; R.W. Gracy. Engineering Dramatic Increases in the Stability of Subtilisin; P.N. Bryan. Increased Stability of Mutant Forms of Yeast Cytochrome c; D.R. Hickey, et al. Introduction to Formulation of Protein Pharmaceuticals; M.A. Hanson, S.K.E. Rouan. PEG Modified Proteins; G.E. Francis, et al. Stabilization of Protein Structure by Solvent Additives; S.N. Timasheff. Heat-Shock Proteins and their Potential Uses for Pharmaceutical Protein Production in Microorganisms; J.M. McCoy. Index.